Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivothrough suppression of PDGFR-β
© Ohishi et al.; licensee BioMed Central Ltd. 2013
Received: 29 November 2012
Accepted: 25 April 2013
Published: 4 May 2013
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|29 Nov 2012||Submitted||Original manuscript|
|Resubmission - Version 2|
|Submitted||Manuscript version 2|
|11 Feb 2013||Reviewed||Reviewer Report - Kristian Pietras|
|14 Feb 2013||Reviewed||Reviewer Report - Gabriel Wcislo|
|15 Apr 2013||Author responded||Author comments - Kazuki Nabeshima|
|Resubmission - Version 3|
|15 Apr 2013||Submitted||Manuscript version 3|
|16 Apr 2013||Reviewed||Reviewer Report - Kristian Pietras|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|25 Apr 2013||Editorially accepted|
|4 May 2013||Article published||10.1186/1471-2407-13-224|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.